Helping Animals Move Better, for Longer

ARTHRAMID IN EUROPE SINCE 2021
Arthramid tech

Supporting Joint Health Across Europe

Dr Jason Lowe and Dr Leigh de Clifford

Arthramid® has been available to veterinarians throughout Europe since 2021, supporting horses and dogs* affected by joint lameness and osteoarthritis.

Behind Arthramid® is a global team of veterinarians, researchers and educators committed to advancing long-term joint health through research, education and clinical support.

Working alongside veterinary professionals across Europe and around the world, Contura Vet continues to foster collaboration, support ongoing research and provide evidence-based education in the management of osteoarthritis.

This commitment to scientific innovation and clinical excellence helps ensure veterinarians across Europe have access to practical guidance, evolving clinical knowledge and long-term support when using 2.5% iPAAG.

Female vet examining golden lab

Long-Term Joint Health Matters

HELPING ANIMALS STAY ACTIVE FOR LONGER
  • For horse owners, it’s about keeping a horse comfortable, capable, and able to continue doing the work they love.
  • For trainers and riders, it’s about recognising changes early and supporting long-term soundness and performance.
  • For dog owners, it’s about everyday quality of life — the walk, the run, the jump into the car, and the excitement that still greets them at the door.
  • For veterinarians, it’s about having access to a treatment supported by research, clinical experience, and ongoing education.

Arthramid exists at the intersection of all of these — supporting long-term joint health through a combination of science, practical experience, and local veterinary support.

Learn More About Arthramid

Global Research. Local Veterinary Support.

Arthramid® is developed by Contura Vet, a company with more than 25 years of experience in joint health technologies across both veterinary and human medicine.

Headquartered in Europe and working alongside veterinary professionals worldwide, Contura Vet continues to support ongoing research, clinical education and scientific innovation in long-term joint health.

This combination of European manufacturing excellence and global research expertise helps ensure veterinarians across Europe have access to consistent product quality, evolving clinical knowledge and long-term support.

*Arthramid is a registered veterinary medicine for the treatment of joint lameness in horses.
Use in canines in Australia and New Zealand is currently extra-label and at the veterinarian’s discretion.

Supporting Better Long-Term Joint Outcomes

Contact Our Team
Vet pulling Arthramid box out of draw

Get The White Paper

This field is for validation purposes and should be left unchanged.

Secret Link